Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 28Glioblastoma 16Gliosarcoma 12Central Nervous System Neoplasms 10Brain Neoplasms 10Astrocytoma 10Glioma 7Oligodendroglioma 6Medulloblastoma 5Ganglioneuroblastoma 5Lymphoma 4Familial ependymoma 4Ependymoma 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroectodermal Tumors, Primitive 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Wilms Tumor 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Sezary Syndrome 2Rhabdoid Tumor 2Ovarian Neoplasms 2

Interventions

Cyclophosphamide 2sargramostim 1poly ICLC 1pembrolizumab 1olaparib 1lutetium Lu 177 dotatate 1lorvotuzumab mertansine 1ixabepilone 1fludarabine 1cixutumumab 1aldesleukin 1Zoledronic Acid 1Trabectedin 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Interleukin-2 1Immunotherapy, Adoptive 1Immunotherapy 1Drug Therapy 1Decitabine 1CLR1404 1Biological Therapy 1Ado-Trastuzumab Emtansine 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × sargramostim × CNS × Clear all
NCT00069940 2010-12-28

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Dana-Farber Cancer Institute

Phase 1 Completed
CNSGastrointestinalSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Leiomyosarcoma, Liposarcoma, Oligodendroglioma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Gliosarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡